Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Filiz Akbıyık"'
Autor:
Merve Hafızoğlu, Arzu Okyar Bas, Ece Tavukçuoğlu, Zeynep Sahiner, Merve Güner Oytun, Sıla Ulutürk, Hamdullah Yanık, Burcu Balam Doğu, Mustafa Cankurtaran, Güneş Esendağlı, Filiz Akbıyık, Banu Çakır, Serhat Ünal, Meltem Gülhan Halil
Publikováno v:
Clinical Immunology Communications, Vol 2, Iss , Pp 154-158 (2022)
Generating memory T cell responses besides humoral immune responses is essential when it comes to the efficacy of a vaccine. In this study, the presence of memory T cell responses after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccine
Externí odkaz:
https://doaj.org/article/07860407cfa34733b36e98f6a6ccbbb9
Autor:
Aslı Çalışkan Arıcan, Yeşim Gökçe Kutsal, Nazire Pınar Acar, Filiz Akbıyık, Sevilay Karahan, Rana Karabudak
Publikováno v:
Türk Osteoporoz Dergisi, Vol 26, Iss 2, Pp 115-120 (2020)
Objective:Osteoporosis (OP) is one of the most frequent metabolic bone disorders worldwide, male OP is still underestimated and undertreated. Primary progressive multiple sclerosis (PPMS) is considered as an important cause of secondary OP in males a
Externí odkaz:
https://doaj.org/article/86f3fe1912024ed5bd89abe5e0241a2a
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 83:194-199
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 82:218-225
Autor:
Gulsen Yilmaz, Sevilay Sezer, Aliye Bastug, Vivek Singh, Raj Gopalan, Omer Aydos, Busra Yuce Ozturk, Derya Gokcinar, Ali Kamen, Jamie Gramz, Hurrem Bodur, Filiz Akbiyik
Publikováno v:
Heliyon, Vol 10, Iss 3, Pp e25410- (2024)
All viruses, including SARS-CoV-2, the virus responsible for COVID-19, continue to evolve, which can lead to new variants. The objective of this study is to assess the agreement between real-world clinical data and an algorithm that utilizes laborato
Externí odkaz:
https://doaj.org/article/8c5670a7efcb40adadf3c83ced9716ed
Autor:
Yigit Sener MD, Mufide Okay MD, Seda Aydin MD, Yahya Buyukasik MD, Filiz Akbiyik MD, Zeliha Gunnur Dikmen MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Bleeding has been reported in patients with chronic myeloid leukemia (CML) using tyrosine kinase inhibitors (TKIs). In this study, we aimed to evaluate platelet functions and associated bleeding symptoms in patients with CML using TKIs. A standardize
Externí odkaz:
https://doaj.org/article/2619aaf02ea34005b87aa59ea1cf0363